On December 16, 2024, in Shenzhen / PR Newswire / -- Today, XtalPi Holdings Limited (stock abbreviation: XtalPi Holdings-P, 2228. HK) announced the signing of a strategic cooperation memorandum with Microsoft China, aiming to collaborate using cutting-edge technologies such as AI, large models, and robotics laboratories, and to actively explore innovative applications of these technologies in the fields of Biomedical and Materials Science, opening a new chapter in scientific research, Education, and innovative applications.

In this cooperation, XtalPi will utilize its expertise from the AI for Science R&D platform and the large multimodal datasets accumulated in its robotics laboratory, combined with Microsoft's large language model (LLM) capabilities, including Azure OpenAI and its high-performance Cloud Computing platform, to explore vertical big models in the fields of new drug or new materials development, and to develop case studies in the area of New Materials design, empowering the sustainable, environmentally friendly, and energy-efficient research and development of new materials. The common goal of both parties is to demonstrate how next-generation computing and automation tools can accelerate innovation in Chemicals and Materials Science, rapidly generating and validating AI-generated molecules that meet necessary attributes and functional standards, and quickly transforming research breakthroughs into competitive products.

XtalPi will also explore deploying its proprietary AI-driven molecular generation and molecular dynamics computation tools on the Microsoft Azure Cloud platform, to further provide powerful computational support, allowing these precise and efficient Asia Vets algorithm tools to effectively serve a broader range of enterprises and scientific research, promoting scientific research innovation on a larger scale, and continuously driving the iterative upgrading of XtalPi's algorithms.

In addition, both parties will explore potential cooperation in the field of academic Education, promoting the introduction of advanced experimental solutions combining AI and automation technologies in academic research, and advancing the digital upgrade of Universities and research Institutions laboratories empowered by the new generation of AI and robotics technology.

Jingtai Technology's AI + Robot platform, as an innovation center, has become an important partner for world-renowned Institutions such as MIT and Singapore's A*STAR, providing R&D services and solutions for over 300 Global companies and research institutions. Jingtai Technology possesses extensive expertise in AI, pharmaceutical R&D, and materials science, demonstrating exceptional performance in providing innovative solutions. Microsoft's technological strength, including powerful Cloud Computing infrastructure and AI capabilities, perfectly complements Jingtai Technology's advantages.

This cooperation comes at a crucial moment when AI technology is profoundly transforming multiple Industries, heralding a new era of enhanced innovation capability and efficiency. The strong alliance between Microsoft and Jingtai Technology, based on their respective comprehensive advantages and technological strengths, will not only drive the development in the pharmaceutical and materials fields but also set an industry benchmark for how to leverage AI to solve complex problems, potentially expanding Jingtai's influence in the materials and Education sectors.

Dr. Wen Shuhai, Chairman of Jingtai Technology, commented: "Microsoft has a cutting-edge research team and strong AI R&D capabilities. Our collaboration reflects a shared vision for the future, where AI and robotics can create opportunities for new generations of innovative breakthroughs, playing a central role in addressing major issues such as human health, environment, and Energy. We look forward to exploring with Microsoft how to enhance the close cooperation between AI, robotics, and human intelligence, thereby expanding our capability to understand and transform the world, and contributing to improving human health and quality of life."

"At Microsoft China, we are committed to harnessing the power of AI and Cloud Computing to drive innovation and support breakthrough research," said Dr. Hou Yang, Senior Vice President of Microsoft and Chairman and CEO of Microsoft Greater China Region. "Our cooperation with Jingtai Technology takes our collaboration in advancing life sciences and materials science a step further. By integrating AI, large language models, and robotics technology, we aim to empower the entire Industry, ultimately contributing to a more innovative and sustainable future."

About XtalPi Technology

XtalPi Technology ("XtalPi Holdings Limited", stock abbreviation: XtalPi Holdings-P, XTALPI-P, stock code: 2228.HK) was founded in 2015 by three physicists from the Massachusetts Institute of Technology. It is an innovative R&D platform powered by AI and driven by Siasun Robot&Automation based on quantum physics. The company combines quantum physics-based first principle calculations, AI, high-performance Cloud Computing, and scalable standardized Siasun Robot&Automation to provide global and domestic companies in the Pharmaceutical and Materials Science (including Agriculture, Energy, New Chemicals, and Cosmetic) industries with drug and materials science R&D solutions and services.

About Microsoft

Microsoft (Nasdaq listing code "MSFT") is committed to achieving digital transformation in the era of "Intelligent Cloud and Intelligent Edge", empowering every person and organization worldwide to achieve extraordinary results.